Amanote Research

Amanote Research

    RegisterSign In

Perspective on the Pipeline of Drugs Being Developed With Modulation of DNA Damage as a Target

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0984
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

September 7, 2010

Authors
R. Plummer
Publisher

American Association for Cancer Research (AACR)


Related search

The Inflammasome as a Target of Modulation by DNA Viruses

Future Virology
Virology
2013English

Dna Damage Mechanisms of Anti-Cancer Drugs

Middle East Journal of Science
2016English

Filamin-A as a Marker and Target for DNA Damage Based Cancer Therapy

DNA Repair
BiochemistryCell BiologyMolecular Biology
2012English

Oxidant-Induced DNA Damage of Target Cells.

Journal of Clinical Investigation
Medicine
1988English

Circadian Modulation of 8-Oxoguanine DNA Damage Repair

Scientific Reports
Multidisciplinary
2015English

DNA Damage Response Inhibition at Dysfunctional Telomeres by Modulation of Telomeric DNA Damage Response RNAs

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

DNA Damage as a Consequence of NLR Activation

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2018English

On Being Cancelled: A Patient's Perspective

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy